Equibles does not estimate personal net worth.
Get an email with a short summary when Neurogene Inc. publishes a filing, an earnings call transcript or a press release.
Get NGNE alertsRachel McMinn is recorded as Chairman and Board Member at Neurogene Inc. (NGNE) since December 18, 2023 and CEO at Neurogene Inc. (NGNE). The newest filing on record that lists Rachel McMinn as CEO at Neurogene Inc. (NGNE) is dated April 16, 2026. Neurogene Inc. reported in an 8-K filed December 19, 2023 that Rachel McMinn was appointed director, effective December 18, 2023. Neurogene Inc. reported in an 8-K filed December 19, 2023 that Rachel McMinn was appointed Chair of the Board, effective December 18, 2023. Neurogene Inc. reported in an 8-K filed December 19, 2023 that Rachel McMinn was appointed Chief Executive Officer, effective December 18, 2023. The proxy statement of Neurogene Inc. reports total compensation of $3,209,553 for Rachel McMinn in fiscal 2025, including a base salary of $618,800. Disclosed compensation is on record for 4 fiscal years. Neurogene Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neurogene Inc. includes David J. Main (CEO), Donna M. Cochener (CEO), Christine Mikail (CFO and Board Member) and 7 others.
“Immediately after the effective time the Merger on December 18, 2023, the Board appointed the following four individuals to the Board: Rachel McMinn, Robert Baffi, Cory Freedland and Keith Woods.”
“Immediately after the effective time the Merger on December 18, 2023, the Board appointed the following four individuals to the Board: Rachel McMinn, Robert Baffi, Cory Freedland and Keith Woods.”
2023-12-18–present
2023-12-18–present
Start not stated–present
Last confirmed April 16, 2026
NGNE
Biotechnology · Healthcare
CEO, Chairman, Board Member
2023-12-18–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Neurogene Inc. (NGNE) | Founder and Chief Executive Officer | $618,800 | $3,209,553 |
| 2024 | Neurogene Inc. (NGNE) | Founder and Chief Executive Officer | $595,000 | $3,464,815 |
| 2023 | Neurogene Inc. (NGNE) | Founder and Chief Executive Officer | $467,890 | $1,080,629 |
| 2022 | Neurogene Inc. (NGNE) | Founder and Chief Executive Officer | $447,741 | $656,545 |
